Laura Lucarini Selected Research

1- ((5- chloro- 1H- indol- 2- yl)carbonyl)- 4- methylpiperazine

1/2019	Effects of PARP-1 Deficiency and Histamine H4 Receptor Inhibition in an Inflammatory Model of Lung Fibrosis in Mice.
1/2018	A Selective Histamine H4 Receptor Antagonist, JNJ7777120, Is Protective in a Rat Model of Transient Cerebral Ischemia.
11/2014	Prevention of bleomycin-induced lung inflammation and fibrosis in mice by naproxen and JNJ7777120 treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laura Lucarini Research Topics

Disease

9	Glaucoma 01/2022 - 11/2014
7	Inflammation (Inflammations) 10/2020 - 03/2014
6	Fibrosis (Cirrhosis) 10/2020 - 11/2014
5	Neoplasms (Cancer) 01/2022 - 11/2014
4	Ischemia 01/2022 - 01/2018
4	Neuralgia (Stump Neuralgia) 10/2021 - 12/2015
4	Airway Remodeling 01/2019 - 03/2014
3	Pain (Aches) 10/2021 - 12/2015
3	Hyperalgesia 10/2021 - 12/2015
3	Ocular Hypertension (Glaucoma, Suspect) 01/2021 - 01/2017
3	Immune System Diseases (Immune Disorders) 01/2019 - 11/2014
3	Marfan Syndrome (Marfan's Syndrome) 01/2018 - 09/2008
3	Pneumonia (Pneumonitis) 01/2016 - 03/2014
3	Scleroatonic muscular dystrophy 08/2007 - 09/2005
2	Neuroinflammatory Diseases 01/2021 - 01/2017
2	Body Weight (Weight, Body) 01/2021 - 01/2018
2	Hypoxia (Hypoxemia) 01/2019 - 12/2018
2	Genomic Instability 03/2018 - 11/2017
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2016 - 11/2014
1	Anaphylaxis (Anaphylactic Shock) 01/2022
1	Reperfusion Injury 01/2022
1	Optic Nerve Diseases (Optic Neuropathy) 11/2021
1	Multiple Sclerosis 01/2021
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2021
1	Rheumatoid Arthritis 12/2020
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 10/2020
1	Arthritis (Polyarthritis) 10/2020
1	Obesity 01/2019
1	Chronic Disease (Chronic Diseases) 01/2019
1	Metabolic Diseases (Metabolic Disease) 01/2019
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2019
1	Overweight 01/2019
1	Renal Cell Carcinoma (Grawitz Tumor) 12/2018
1	Thoracic Aortic Aneurysm 01/2018
1	Loeys-Dietz Syndrome 01/2018
1	Type 2 Diabetes Mellitus (MODY) 01/2018
1	Brain Ischemia (Cerebral Ischemia) 01/2018
1	Transient Ischemic Attack 01/2018

Drug/Important Bio-Agent (IBA)

6	Histamine (Histamine Dihydrochloride)FDA Link 01/2022 - 12/2015
6	Histamine H4 ReceptorsIBA 01/2019 - 11/2014
6	CollagenIBA 01/2017 - 09/2005
5	Bleomycin (Blenoxane)FDA LinkGeneric 10/2020 - 11/2014
4	Carbonic Anhydrases (Carbonic Anhydrase)IBA 01/2022 - 12/2018
4	LigandsIBA 11/2021 - 01/2016
4	CytokinesIBA 01/2021 - 03/2014
4	Pharmaceutical PreparationsIBA 12/2020 - 11/2014
4	Protein Isoforms (Isoforms)IBA 01/2020 - 11/2014
4	EnzymesIBA 03/2018 - 05/2009
4	Transforming Growth Factor-beta Type I ReceptorIBA 01/2018 - 09/2008
3	Carbonic Anhydrase InhibitorsIBA 12/2020 - 01/2017
3	1- ((5- chloro- 1H- indol- 2- yl)carbonyl)- 4- methylpiperazineIBA 01/2019 - 11/2014
3	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 03/2018 - 03/2014
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 03/2018 - 03/2014
3	Transforming Growth Factor-beta Type II ReceptorIBA 01/2018 - 09/2008
2	Retinaldehyde (Retinal)IBA 01/2022 - 11/2021
2	Histamine Receptors (Histamine Receptor)IBA 10/2021 - 12/2015
2	Interleukin-10 (Interleukin 10)IBA 10/2021 - 01/2019
2	S-(2-guanidylethyl)isothioureaIBA 10/2021 - 01/2017
2	FructoseIBA 01/2021 - 01/2018
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2018
2	LipidsIBA 01/2021 - 01/2018
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 12/2020 - 10/2020
2	dorzolamide (Trusopt)FDA LinkGeneric 01/2020 - 11/2014
2	carbomerIBA 02/2019 - 10/2017
2	Peroxidase (Myeloperoxidase)IBA 01/2019 - 01/2016
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2018 - 05/2014
2	Fluorouracil (Carac)FDA LinkGeneric 03/2018 - 11/2017
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2016 - 11/2014
1	Endothelin-1 (Endothelin 1)IBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 10/2021
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 10/2021
1	N(6)- (3- iodobenzyl)- 5'- N- methylcarboxamidoadenosineIBA 10/2021
1	avanafilIBA 01/2021
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021
1	Insulin (Novolin)FDA Link 01/2021
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2021
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2021
1	AmidesIBA 12/2020
1	BenzenesulfonamidesIBA 01/2020
1	ciproxifanIBA 02/2019
1	6- ((3- cyclobutyl- 2,3,4,5- tetrahydro- 1H- 3- benzazepin- 7- yl)oxy)- N- methyl- 3- pyridinecarboxamideIBA 02/2019
1	Olive OilIBA 01/2019
1	AntioxidantsIBA 01/2019
1	Superoxides (Superoxide)IBA 01/2019
1	CaspasesIBA 01/2019
1	AdiponectinIBA 01/2019
1	Antineoplastic Agents (Antineoplastics)IBA 12/2018
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 12/2018
1	Proteins (Proteins, Gene)FDA Link 12/2018
1	Carbonic Anhydrase IXIBA 12/2018
1	Melatonin Receptors (Melatonin Receptor)IBA 01/2018
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2018
1	MonosaccharidesIBA 01/2018
1	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 01/2018
1	tagatose (D-tagatose)IBA 01/2018
1	Neuroprotective AgentsIBA 01/2018

Therapy/Procedure

4	Therapeutics 01/2021 - 01/2016
1	Intravenous Administration 10/2021
1	Lasers (Laser) 01/2021
1	Mediterranean Diet 01/2019